New

Alcon

The AI engine Fit Assessment

Beta

Alcon develops and manufactures medicines and devices for ophthalmology, supported by extensive R&D and a broad portfolio, which aligns with pharma tech-focused central requirements.

Blurb

Alcon specializes in developing and manufacturing innovative medicines and devices to serve the cycle of eye care.

HQ Location

Vernier (Switzerland)

Founded

1945

Employees

10000+

Total funding raised

$22.80B

Funding Status

Acquired by Novartis, December 2010

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.